Crossbow Therapeutics
Signal active
Organization
Contact Information
Overview
Crossbow Therapeutics is a seed-stage, stealth-mode oncology startup company. The company develops antibody engineering for intracellular cancer targets.
About
Industries
Biotechnology, Life Science, Health Care, Medical, Oncology
Founded
2021
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Crossbow Therapeutics headquartered in United States, North America, operates in the Biotechnology, Life Science, Health Care, Medical, Oncology sector. The company focuses on Biotechnology and has secured $1.6B in funding across 20 round(s). With a team of 11-50 employees, Crossbow Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Crossbow Therapeutics, raised $80.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
7
Lead Investors
0
Total Funding Amount
$80.0M
Details
1
Crossbow Therapeutics has raised a total of $80.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Early Stage Venture | 80.0M |
Investors
Crossbow Therapeutics is funded by 11 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Pfizer Venture Investments | - | FUNDING ROUND - Pfizer Venture Investments | 80.0M |
| Mirae Asset Venture Investment | - | FUNDING ROUND - Mirae Asset Venture Investment | 80.0M |
| Crossbow Therapeutics | - | FUNDING ROUND - Crossbow Therapeutics | 80.0M |
| Biotechnology Value Fund | - | FUNDING ROUND - Biotechnology Value Fund | 80.0M |
Recent Activity
There is no recent news or activity for this profile.